Singapore markets closed

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)

SES - SES Delayed Price. Currency in USD
Add to watchlist
0.9450-0.0100 (-1.05%)
At close: 02:57PM SGT

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Zhong Xin Mansion
No. 17 Baidi Road Nankai District
Tianjin 300193
China
86 22 2702 0892
https://www.zhongxinp.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees4,650

Key executives

NameTitlePayExercisedYear born
Ms. Niu ShengfangDeputy GM & Deputy Chief Accountant148.46kN/A1975
Mr. Jian ZhangDeputy Gen. Mang.148.46kN/A1963
Ms. Xin WangDeputy Gen. Mang.154.62kN/A1970
Ms. Lei WangGen. Mang.N/AN/A1971
Mr. Hong ZhouDeputy GM, Chief Engineer & Exec. DirectorN/AN/A1970
Mr. Mai WangEmployee Director and Chairman of the Union & Director of the organization departmentN/AN/A1970
Mr. Min GuoExec. DirectorN/AN/A1971
Mr. Yu ZhangChief Production OfficerN/AN/AN/A
Ms. Yan JiaoSec. to the Board of DirectorsN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.

Corporate governance

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.